Friday, March 17, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home News Scan

Biodefense Headlines – September 27, 2015

by Global Biodefense Staff
September 27, 2015

Parents in poor countries worry about vaccines, too | HHS advances development of new monoclonal antibody drug for Ebola | FDA to hire top lab safety official after report details gaps | Non-antibiotic drug shows promise in deadly C. difficile infections | Testing radiation detection systems in harsh conditions | Liberia struggles to regain economic footing after Ebola | When radiation isn’t the real risk | U.S. defense agencies dominate federal synthetic biology research | Enhanced airport entry screening to end for travelers from Liberia to U.S. | WHO panel changes 2 strains in Southern Hemisphere flu vaccine | Bird flu vaccine conditionally approved, but still can’t be sold | Asia’s biggest vaccine maker to seek fast-track nod for dengue drug in India | Iowa company gets first USDA-issued conditional license to develop bird flu vaccine | GAO finds National Biosurveillance Integration Center lacking | Ben Carson doesn’t get it: All our vaccines prevent death | WHO responds as Yemen as health facilities continue to shut down | FDA awards 18 grants to stimulate product development for rare diseases | New human virus discovered in old blood samples | Study adds to evidence that viruses are alive | After five years of delay, WMD plan is ‘nonsensical,’ critics say | Kansas City sees spike in Shigella infections | Big price increase for tuberculosis drug is rescinded | Refugees and migrants are more prone to foodborne diseases

See what we’re reading this week at Global Biodefense on topics including radiation detection systems, Shigella spike in the U.S., the bird flu vaccine and more…

Parents in poor countries worry about vaccines, too (NPR)

HHS advances development of new monoclonal antibody drug for Ebola (HHS)

FDA to hire top lab safety official after report details gaps (CIDRAP)

Non-antibiotic drug shows promise in deadly C. difficile infections (Reuters)

Testing radiation detection systems in harsh conditions (HSNW)

Liberia struggles to regain economic footing after Ebola (Reuters)

When radiation isn’t the real risk (NY Times)

U.S. defense agencies dominate federal synthetic biology research (HSNW)

Enhanced airport entry screening to end for travelers from Liberia to U.S. (CDC)

WHO panel changes 2 strains in Southern Hemisphere flu vaccine (CIDRAP)

Bird flu vaccine conditionally approved, but still can’t be sold (NY Times)

Asia’s biggest vaccine maker to seek fast-track nod for dengue drug in India (Reuters)

GAO finds National Biosurveillance Integration Center lacking (CIDRAP)

Ben Carson doesn’t get it: All our vaccines prevent death (Forbes)

WHO responds as Yemen as health facilities continue to shut down (WHO)

FDA awards 18 grants to stimulate product development for rare diseases (FDA)

New human virus discovered in old blood samples (Science)

Study adds to evidence that viruses are alive (EurekAlert)

After five years of delay, WMD plan is ‘nonsensical,’ critics say (Reuters)

Kansas City sees spike in Shigella infections (CNN)

Big price increase for tuberculosis drug is rescinded (NY Times)

Refugees and migrants are more prone to foodborne diseases (WHO)

Related Posts

Biodefense Headlines – 12 March 2023
News Scan

Biodefense Headlines – 12 March 2023

March 12, 2023
Biodefense Headlines – 24 January 2023
News Scan

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023
News Scan

Biodefense Headlines – 17 January 2023

January 17, 2023
Biodefense Headlines – 10 January 2023
News Scan

Biodefense Headlines – 10 January 2023

January 10, 2023
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC